Synonyms: BBR-2778 | Pixuvri®
pixantrone is an approved drug (EMA and UK (2012))
Compound class:
Synthetic organic
Comment: Pixantrone is an antineoplastic drug that also shows immunosuppressant activity [4-5]. It is administered clinically as pixantrone dimaleate (PubChem CID: 9937618).
|
|
References |
1. Adnan N, Buck DP, Evison BJ, Cutts SM, Phillips DR, Collins JG. (2010)
DNA binding by pixantrone. Org Biomol Chem, 8 (23): 5359-66. [PMID:20865205] |
2. De Isabella P, Palumbo M, Sissi C, Capranico G, Carenini N, Menta E, Oliva A, Spinelli S, Krapcho AP, Giuliani FC et al.. (1995)
Topoisomerase II DNA cleavage stimulation, DNA binding activity, cytotoxicity, and physico-chemical properties of 2-aza- and 2-aza-oxide-anthracenedione derivatives. Mol Pharmacol, 48 (1): 30-8. [PMID:7623772] |
3. Evison BJ, Mansour OC, Menta E, Phillips DR, Cutts SM. (2007)
Pixantrone can be activated by formaldehyde to generate a potent DNA adduct forming agent. Nucleic Acids Res, 35 (11): 3581-9. [PMID:17483512] |
4. Marolda R, Ruocco C, Cordiglieri C, Toscani C, Antozzi C, Mantegazza R, Baggi F. (2013)
Differential targeting of immune-cells by Pixantrone in experimental myasthenia gravis. J Neuroimmunol, 258 (1-2): 41-50. [PMID:23523328] |
5. Mazzanti B, Biagioli T, Aldinucci A, Cavaletti G, Cavalletti E, Oggioni N, Frigo M, Rota S, Tagliabue E, Ballerini C et al.. (2005)
Effects of pixantrone on immune-cell function in the course of acute rat experimental allergic encephalomyelitis. J Neuroimmunol, 168 (1-2): 111-7. [PMID:16120465] |